BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine

Atlanta (ots) - Germany will present itself as one of the world's
leading regenerative medicine research locations at this year's BIO
International Convention. Under the "Breakthroughs in Regenerative
Medicines in Germany" banner, German experts will provide invaluable
insight into the latest research results in the area of regenerative
medicine in Germany. The German research landscape and the regulatory
framework conditions will be introduced in a presentation in which
the most recent industry successes will also be demonstrated.

Dr. Manfred Rüdiger, CEO of Frankfurt-based t2cure GmbH, and Prof.
Dr. Georg N. Duda, Vice Director of the Berlin-Brandenburg Center for
Regenerative Therapies (BCRT), will also speak at the Germany Trade &
Invest-organized event. Both are experts and active partners in the
German research and enterprise landscape in the area of regenerative
medicine.

Regenerative medicine offers rich and varied potential at a time
when western social welfare states are confronted with the problem of
rapidly aging populations and overloaded health systems. It is
generally expected that not only should the quality of life of the
patient be improved by regenerative treatments, but also that health
systems be sustainably disburdened by eliminating protracted
aftercare and complications. Germany takes center-stage in the
presentation as an innovative location with favorable research
conditions.

In this respect, highlighted in particular is the excellent
cross-linking among German universities as well as with other
research and development institutions. In combination with the strong
political will to actively promote promising regenerative medicine
projects, the high quality of existing research networks provide a
strong argument for investment in Germany.

As well as highlighting German initiative-led successes in
regenerative medicine to date, the event at the Georgia World
Congress Center in Atlanta will also illustrate future growth
potential within the sector in Germany.

The annual BIO International Convention is the largest global
event for the biotechnology industry. It takes place at changing
locations within the USA and attracts participating exhibitors from
around 50 countries. This year's BIO takes place until Thursday, May
21, 2009, at the Georgia World Congress Centers in Atlanta. The
German Pavilion is located in Building B, Hall B2.

Germany Trade & Invest is the foreign trade and inward investment
promotion agency of the Federal Republic of Germany. The organization
advises and supports foreign companies seeking to expand into the
German market and assists companies established in Germany looking to
enter foreign markets.

Originaltext: Germany Trade and Invest
digital press kits: http://www.presseportal.de/pm/74441
press kits via RSS: http://www.presseportal.de/rss/pm_74441.rss2

Media Contact:
Eva Henkel
Email: eva.henkel@gtai.com
Phone: +49 (0)30-200099-173
Fax: +49 (0)30-200099-111